Data / Form D filings / Osmol Therapeutics, Inc.
Osmol Therapeutics, Inc.: Form D filings
Osmol Therapeutics, Inc., a biotechnology company in New Haven, CT, filed 2 Form D notices with the SEC between 2017 and 2022. The latest, on February 28, 2022, reports $2.3 million sold of a $7.5 million offering to 4 investors.
Find out what Osmol Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 33 WHITNEY AVENUE, Suite 2B, New Haven, CT, 06510
- Phone
- (617) 719-9406
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1694244
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | New notice | $7,500,000 | $2,300,000 | $5,200,000 | 4 | Feb 14, 2022 | sec.gov |
| Jan 18, 2017 | New notice | $3,050,000 | $550,000 | $2,500,000 | 4 | Dec 21, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Ehrlich | Director | |
| Robert Berman | Director | |
| Robert Linke | Executive Officer, Director | |
| Vlad Coric | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Feb 28, 2022 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Osmol Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.